TPG and Temasek-backed Dr Agarwal’s Healthcare IPO opens for subscription on tomorrow (Wednesday, January 29). The company offers a comprehensive range of eye care services, including cataract ...

Dr Agarwal's Healthcare received modest response from investors. The IPO, which was subscribed just over 1.4 times, will see its share allotment get finalised later today. Investors can check Dr ...

Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...

Are you searching for newly listed stocks to invest in long-term perspective? Analysts from domestic brokerage have initiated coverage on Dr Agarwal's Health Care stock with a potential upside of ...

Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.

In the first two months of 2025, nine mainboard firms launched their IPOs, collectively raising Rs 15,723 crore, while 40 SMEs made their debut, securing nearly Rs 1,804 crore.

Dr Agarwal's Health Care IPO comprised a fresh issue of up to ₹300 crore alongside an Offer For Sale (OFS) of up to 6.78 crore equity shares valued at ₹2,727.26 crore by promoters and other ...

(($50 million+$21 million+$173 million+$21 million)). Dr Agarwal's Health Care: The IPO lock-in period will expire on March 3, 2025. It could free up 10.9 million shares, amounting to a total ...